查詢結果分析
相關文獻
- Comparison of Intravenous Granisetron with Metoclopramide Plus Dexamethasone in the Prevention of Nausea and Vomiting Associated with Emetogenic Cytotoxic Chemotherapy
- 薑對癌症病人因化學藥物治療引起噁心與嘔吐之控制成效--系統性回顧暨統合分析
- 應用噁心嘔吐量表於癌症病童之經驗
- Validity of Two Instruments Measuring Nausea and Vomiting by Children Who Received Cancer Chemotherapy
- Serotonin Receptor Antagonists用來治療噁心、嘔吐
- 噁心和嘔吐的處置
- Prevention of PONV with Dexamethasone in Female Patients Undergoing Desflurane Anesthesia for Thyroidectomy
- Prevention of Acute and Delayed Cisplatin-Induced Nausea and Vomiting with Intravenous Ondansetron Plus Intravenous Dexamethasone
- 噁心嘔吐之居家照護
- 婦女孕期噁心嘔吐之內心感受與護理需求
頁籤選單縮合
題 名 | Comparison of Intravenous Granisetron with Metoclopramide Plus Dexamethasone in the Prevention of Nausea and Vomiting Associated with Emetogenic Cytotoxic Chemotherapy=Granisetron與Metoclopramide/Dexamethasone於化學藥物引起之噁心嘔吐預防效果之比較研究 |
---|---|
作 者 | 張肇松; 陳立宗; 黃叔牧; 劉大智; 林勝豐; 陳田柏; 魏德芝; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷 期 | 13:2 1997.02[民86.02] |
頁 次 | 頁97-102 |
分類號 | 418.8 |
關鍵詞 | 化學藥物; 噁心; 嘔吐; Granisetron; Antiemetic; Chemotherapy; |
語 文 | 英文(English) |
中文摘要 | 本研究主要目的在評估與比較一個新的5-HT3拮抗劑,Granisetron,和目前所使用的標準止吐劑,Metoclopramide加上Dexamethasone在對於第一次接受化學治療的腫瘤病人所引起的噁心嘔吐的預防效果。結果顯示在化學治療後第一天噁心嘔吐的預防效果於Granisetron治療組與Metoclopramide加上Dexamethasone的控制組分別為84%與95%;而在往後六天的效果則為77%與60%,兩組結果無顯著差別。而在藥物副作用上,Granisetron治療沮則比Metoclopramide加上Dexamethasone的控制組較少且無椎體外症候群。因此我們結論,以單一劑量3mg的Granisetron來預防化學治療引起的噁心嘔吐與傳統Metoclopramide加上Dexamethasone具有同等的效果且副作用較少,Granisetron單一劑量是一種簡便有效的預防化學治療引起的噁心嘔吐方法。 |
英文摘要 | Fifty-one patients who received their first course of chemotherapy were studied to compare the respective efficacy and safety of granisetron and metoclopramide plus dexamethasone in the prevention of nausea and vomiting induced by emetogenic cytotoxic drugs. The results showed the response rate of antiemesis in the first 24 hours was higher in the metoclopramide plus dexamethasone group than in the granisetron group: 95% vs 84%. For the next six days of the study period, the response rate of the granisetron group was shown to be more effective than that of metoclopramide plus dexamethasone group: 77% vs 60%. Furthermore, the granisetron seemed to display enhanced tolerability with less drug-related side effects and no extrapyramidal effects which appeared in 2 cases of the metoclopramide plus dexamethasone group. In conclusion, a single dose of granisetron can be as effective as the gold standard of metoclopramide plus dexamethasone regimen in preventing and treating acute nausea and vomiting. For preventing delayed nausea and vomiting, granisetron is shown to be more effective than metoclopramide plus dexamethasone. |
本系統中英文摘要資訊取自各篇刊載內容。